Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Intend to be skeptical like you, my ramblin friend. Here’s what I see in today’s news—a HUGE potential for the FUTURE that Amniostem portends. As I read it, this is an “add-on” to the already existing patent for Amniostem: kudos to the CELZ team for seeing a potentially hug and unexpected opening just ONE MONTH ago when President Trump signed the “right to try” order. These CELZ scientists are VERY cautious and circumspect: the already know that Amniostem will do what they think it should, and in the ways that the FDA requires—otherwise they (a) wouldn’t waste their time and (b) wouldn’t announce it. If you’ve ever had a loved one suffer through chemo and radiation for cancer, you know how real (and sad) cachexia is. Now here’s the MOST beautiful part (at least as I see things): because an emaciated body fights less capably than a more robust one, I see a HUGE potential for insurance coverage of Amniostem for this medical indication (providing again that it develops, both medically and procedurally, in the ways that the CELZ scientists expect it will). Therefore, good luck to insurance companies trying to argue in favor of maintaining weak and emaciated patients, when this alternative is available.